Bovine lactoferrin prevents lethality of mice treated with recombinant tumor necrosis factor alpha and galactosamine

Central-European Journal of Immunology

Volumn 25, Issue 2, 2000, Pages 76-80

  Machnicki, M ^a   Zimecki, M ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Galactosamine; IL 1; Lactoferrin; LPS; Protection; TNF

Indexed keywords

AUTACOID; CYTOKINE; GALACTOSAMINE; HUMAN SERUM ALBUMIN; IMMUNOSUPPRESSIVE AGENT; LACTOFERRIN; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; LIVER FUNCTION; LIVER PROTECTION; MOUSE; NONHUMAN; RETICULOENDOTHELIAL SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0034519615     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lactoferrin and the inflammatory response
2. The macrophage as production site for hematopoietic regulator molecules: Sensing and responding to normal and pathophysiological signals
3. Lactoferrin-lipopolysaccharide interactions. Effect of lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells
4. Expression of human lactoferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors and antiligand-affinity chromatography
5. Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines in serum-free medium
6. Isolation and partial characterization of a lactoferrin receptor from mouse intestinal brush border
7. Lactoferrin effects on the in vitro immune response in critically ill patients
8. Immunostimulatory activity of lactotransferrin and maturation of CD4- CD8-lymphocytes
9. Human lactoferrin induces phenotypic and functional changes in splenic mouse B cells
10. Lactoferrin inhibits proliferative response and cytokine production by TH1 but not TH2 cells
11. Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cells
12. Lactoferrin increases the output of neutrophil precursors and atteunates the spontaneous production of TNF-α and IL-6 by peripheral blood cells
13. Lactoferrin lowers serum interleukin 6 and tumor necrosis factor α levels in mice subjected to surgery
14. Early response in neonatal septicemia. The effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on the generation of lactoferrin
15. Early fall of circulating iron and rapid rise of lactoferrin in septicemia and endotoxemia: An early defence mechanism
16. Lactoferrin regulates the release of tumor necrosis factor alpha and interleukin 6 in vivo
17. Supplementation of an adapted formula with bovine lactoferrin. I. Effect on the infant faecal flora
18. Antibacterial prophylaxis with lactoferrin in neutropenic patients
19. Inactivation of Listeria monocytogenes by lactoferricin, a potent antimicrobial peptide derived from cow's milk
20. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo
21. The bacteriostatic effects of orally administered bovine lactoferrin on intestinal Enterobacteriaceae of SPF mice fed bovine milk
22. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients
23. Four different interleukin-1 species sensitize to the lethal action of tumor necrosis factor
24. Interleukin 1 potentiates the lethal effect of tumor necrosis factor (cachectin in mice
25. Galactosamine hepatitis: Key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death
26. Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor
27. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor alpha in mice
28. Interleukin 10 is a control regulator of the response to LPS in murine models of endotoxic shock and the Schwartzman reaction but not endotoxin tolerance
29. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
30. Inteleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
31. Pharmacoimmunodynamic interactions of interleukin 10 and prednisone in healthy volunteers
32. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses
33. Interleukin 10 protects mice from lethal endotoxemia
34. Interleukin 10 (IL-10) upregulated IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation
35. Antiinflammatory response during clinical sepsis and experimental endotoxemia: Sequential measurements of plasma soluble interleukin (IL-1)-1 receptor type II, IL-10, and IL-13